What’s next for patient advocacy?
Virtual event from OVID and the Patient Partnership Index is now open for registration
Read MoreVirtual event from OVID and the Patient Partnership Index is now open for registration
Read MoreOfficials warned that early evidence suggests there may be an increased risk of hospitalisation for Delta compared to the Alpha (Kent) strain
Read MoreIf approved, up to 2,000 children with CF would be eligible for treatment with the drug
Read MoreCost-effectiveness estimates have fallen above the threshold because of uncertain trial evidence
Read MoreAround 270 people with PNH and 160 people with aHUS will be eligible for the new treatment
Read MorePharmaTimes Media Ltd.
Mansard House
Church Road
Little Bookham
Leatherhead
Surrey KT23 3JG
E: editorial@pharmatimes.com
E: subscriptions@pharmatimes.com
T: +44 (0)20 7240 6999
F: +44 (0)20 7240 4479